Revenue: The sum of all revenue fields included for a company's operating activities.
Gyre Therapeutics, Inc. (GYRE) had Revenue of $29.11M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$29.11M |
$-11.66M |
|
$2.21M |
|
$26.90M |
|
$43.47M |
|
$-14.36M |
|
$-0.07M |
|
$-14.43M |
|
$-14.43M |
|
$-14.27M |
|
$-14.27M |
|
$-14.27M |
|
$-14.27M |
|
$-14.36M |
|
$-12.89M |
|
100.64M |
|
100.64M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$122.07M |
|
$27.28M |
|
$77.18M |
|
$199.25M |
|
$28.66M |
|
-- |
|
$5.67M |
|
$34.34M |
|
$142.49M |
|
$160.39M |
|
$164.92M |
|
106.03M |
|
| Cash Flow Statement Financials | |
$-13.55M |
|
$6.70M |
|
$0.01M |
|
$49.19M |
|
$43.29M |
|
$-5.91M |
|
$4.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
92.41% |
|
-49.35% |
|
-49.35% |
|
-- |
|
-49.59% |
|
-40.07% |
|
$-13.97M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.19 |
|
1.04 |
|
86.63 |
|
-10.01% |
|
-8.90% |
|
-7.16% |
|
-8.65% |
|
$1.56 |
|
$-0.14 |
|
$-0.13 |
|